Comparing In-Person vs. Virtual Support for Preventing Postpartum Depression

This study is testing two ways to deliver the ROSE Program (Reach Out, Stay Strong, Essentials for New Moms), a group-based support program designed to prevent postpartum depression. One group will receive the program in person, and another will receive it virtually through telehealth. Both versions cover topics like building social support, improving communication, and understanding the transition to motherhood. The goal is to see if the virtual ROSE Program works as well as the in-person version. You may be able to join if you are a woman, 18 years or older, speak English or Spanish, and are less than 30 weeks pregnant. Researchers will measure success by looking at your depression symptoms at 6 weeks, 3 months, and 6 months after birth. The study is currently recruiting participants.

Study design
This is an interventional study planning to enroll 900 participants. Participants will be randomly assigned to receive either the in-person or virtual ROSE Program.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after birth, with depression symptoms measured at 6 weeks, 3 months, and 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05766475

In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression

Recruiting
NAAges 18+InterventionalPrevention
University of Denver
~900 participants
Updated 2023-05-17 on ClinicalTrials.gov
What's tested:ROSE Program: In PersonROSE Program: Virtual

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Symptom Checklist 20 (SCL 20)
Measured over 6 weeks after birth
+7 more outcomes measured
Postpartum Depression
1 sites across 1 states
Colorado1
  • Galena Rhoades, PhD · PRINCIPAL_INVESTIGATOR · University of Denver
  • Elysia P Davis, PhD · PRINCIPAL_INVESTIGATOR · University of Denver

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

English or Spanish speaking
Less than 30 gestational weeks

Exclusion

None
  • Symptom Checklist 20 (SCL 20)6 weeks after birth

    Self reported depression scores. Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.

  • Symptom Checklist 20 (SCL 20)3 months after birth

    Self reported depression scores.Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.

  • Symptom Checklist 20 (SCL 20)6 months after birth

    Self reported depression scores

  • Symptom Checklist 20 (SCL 20)12 months after birth

    Self reported depression scores. Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.

  • Center for Epidemiologic Studies Depression Scale (CES-D)6 weeks after birth

    Self reported depression scores. Possible range of scores is 0 to 60, with the higher scores indicating higher depression levels.

  • Center for Epidemiologic Studies Depression Scale (CES-D)3 months after birth

    Self reported depression scores. Possible range of scores is 0 to 60, with the higher scores indicating higher depression levels.

  • Center for Epidemiologic Studies Depression Scale (CES-D)6 months after birth

    Self reported depression scores. Possible range of scores is 0 to 60, with the higher scores indicating higher depression levels.

  • Center for Epidemiologic Studies Depression Scale (CES-D)12 months after birth

    Self reported depression scores. Possible range of scores is 0 to 60, with the higher scores indicating higher depression levels.